[1]MartínDomínguez V,GonzálezCasas R,MendozaJiménezRidruejo J,et al. Pathogenesis,diagnosis and treatment of nonalcoholic fatty liver disease[J]. Rev Esp Enferm Dig,2013,105(7):409420.
[2]雷嘉川,余建清,廖志雄.决明子抗氧化作用的研究[J].中国中医药信息杂志,2006,13(11):4142.
[3]罗先钦,徐晓玉,黄崇刚.决明子总蒽醌对酒精性脂肪肝大鼠肝组织脂质过氧化与PPARγ表达的影响[J]. 中国中药杂志,2011,36(12):16541659.
[4]陈依雨,李博萍,赵汝霞,等.决明子提取物对脂肪肝大鼠眼晶状体抗氧化能力的影响[J].广东药学院学报,2013,29(3):288291.
[5]郑琳颖,潘竞锵,杨以琳,等.白芍总苷对非酒精性脂肪性肝病大鼠Apelin和Visfatin表达的影响[J].中药新药与临床药理,2013,24(1):5154.
[6]Basaranoglu M,Basaranoglu G,Sabuncu T,et al. Fructose as a key player in the development of fatty liver disease[J]. World J Gastroenterol,2013,19(8):11661172.
[7]de Castro UG,dos Santos RA,Silva ME,et al. Agedependent effect of highfructose and highfat diets on lipid metabolism and lipid accumulation in liver and kidney of rats[J]. Lipids Health Dis,2013,(12):136.
[8]郑琳颖,潘竞锵,吕俊华.白芍总苷对脂肪肝大鼠增强胰岛素敏感性及抗脂肪肝作用[J].中国中药杂志,2008,33(20):23852390.
[9]Razavizade M, Jamali R, Arj A, et al. The Effect of Pioglitazone and Metformin on Liver Function Tests,Insulin Resistance,and Liver Fat Content in Nonalcoholic Fatty Liver Disease: A Randomized Double Blinded Clinical Trial[J]. Hepat Mon,2013,13(5): 9270.
[10]LI Y,LIU L,WANG B,et al.Metformin in nonalcoholic fatty liver disease: A systematic review and metaanalysis[J]. Biomedical Reports,2013,1(1):5764.
[11]Younessi P,Yoonessi A. Advanced glycation endproducts and their receptormediated roles: inflammation andoxidative stress[J]. Iran J Med Sci,2011,36(3):154166.(收稿日期:20140904)
[1]秦灵灵 王磊 李娟娥 刘铜华.仙鹤草对2型糖尿病大鼠胰岛素抵抗及炎性因子
的干预作用[J].环球中医药,2013,6(05):333.
QIN Ling ling,WANG Lei,LI Juan e,et al.Effects of Herba Agrimoniae on insulin resisitance and inflammatory factors in T2DM rats[J].,2013,6(10):333.
[2]赵轩,高彦彬,朱智耀,等.糖脂平对胰岛素抵抗大鼠骨骼肌氧化应激的影响[J].环球中医药,2014,7(05):333.
ZHAO Xuan,GAO Yan bin,ZHU Zhi yao,et al.Effects of Tangzhiping on oxidative stress in rat insulin resistance model[J].,2014,7(10):333.